GLP-1 medication and lifestyle program for teen weight management
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests a GLP-1 medication (a drug that helps control appetite and blood sugar) combined with a lifestyle program for teens with severe obesity. The goal is to see if this approach can improve overall health and well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 18 years old
- Your weight puts you in the 95th percentile or above for your age and sex
- You do not have type 1 or type 2 diabetes
- You have not taken any prescription weight-loss medications in the past 6 months
- You have not had weight-loss surgery and are not planning to have it during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how the body adapts to weight loss in teens with obesity. You will either get a behavioral lifestyle program alone or with a weight loss medication called semaglutide.
This study tests whether a medication that helps with weight loss, called a GLP-1 agonist, can also change how the brain works. It is for teenagers (12-18) and adults (30-45) with obesity.
This trial studies whether semaglutide (a once-weekly injection) helps adolescents with a specific genetic form of obesity lose weight. It is for teens who are already being prescribed semaglutide as part of their regular care.
This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.
This study looks at how teenagers and young adults respond to weight-loss surgery (sleeve gastrectomy) and whether adding a medication called semaglutide can help improve weight loss. It has two parts: first observing how surgery affects you, then testing if semaglutide helps those who didn't lose enough weight after surgery.
This study tests whether semaglutide (a once-weekly injection that helps with weight loss) can help teenagers with autism who are obese. It will compare their results to similar teens who did not take the drug to see if it is safe and effective.
Hear when a new Obesity, Childhood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.